Signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages

Molecular Medicine

Volumn 18, Issue 8, 2012, Pages 1231-1239

  Braga, Tarcio Teodoro ^a   Correa Costa, Matheus ^a   Guise, Yuri Felipe Souza ^a   Castoldi, Angela ^b   de Oliveira, Cassiano Donizetti ^b   Hyane, Meire Ioshie ^a   Cenedeze, Marcos Antonio ^b   Teixeira, Simone Aparecida ^a   Muscara, Marcelo Nicolas ^a   Perez, Katia Regina ^a   Cuccovia, Iolanda Midea ^a   Pacheco Silva, Alvaro ^b   Gonçalves, Giselle Martins ^a   Camara, Niels Olsen Saraiva ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; CD11B ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MYELOID DIFFERENTIATION FACTOR 88; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; IMMUNOPATHOGENESIS; KIDNEY FIBROSIS; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH1 TH2 BALANCE; TH2 CELL; ANIMAL; C57BL MOUSE; FIBROSIS; HEMATOPOIESIS; IMMUNITY; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; LIGATION; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; URETER; URETER OBSTRUCTION;

ANIMALS; CYTOKINES; FIBROSIS; HEMATOPOIESIS; IMMUNITY; INTERLEUKIN-12; INTERLEUKIN-4; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIGATION; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; TH2 CELLS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; URETER; URETERAL OBSTRUCTION;

EID: 84869128422     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00131     Document Type: Article

References (37)

1. Mangione F, Dal Canton A. (2010) The epidemic of chronic kidney disease: looking at ageing and cardiovascular disease through kidney-shaped lenses. J. Intern. Med. 268:449-55.
2. Nagle RB, Bulger RE, Cutler RE, Jervis HR, Benditt EP. (1973) Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic, and histochemical changes. Lab. Invest. 28:456-7.
3. Bascands JL, Schanstra JP. (2005) Obstructive nephropathy: insights from genetically engineered animals. Kidney Int. 68:925-37.
4. Pulskens WP, et al. (2010) TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J. Am. Soc. Nephrol. 21:1299-308.
5. Pradere JP, Troeger JS, Dapito DH, Mencin AA, Schwabe RF. (2010) Toll-like receptor 4 and hepatic fibrogenesis. Semin. Liver Dis. 30:232-44.
6. Leemans JC, et al. (2009) The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One. 4:e5704.
7. Skuginna, et al. (2011) Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction. PLoS One. 6:e19204.
8. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 440:237-41.
9. Kool M, et al. (2011) An unexpected role for uric Acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity. 34:527-40.
10. Cheever AW, et al. (1994) Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egginduced hepatic fibrosis. J. Immunol. 153:753-9.
11. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA. (1999) An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104:777-85.
12. Reiman RM, et al. (2006) Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect. Immun. 74:1471-9.
13. Sung SA, Jo SK, Cho WY, Won NH, Kim HK. (2007) Reduction of renal fibrosis as a result of liposome encapsulated clodronate induced macrophage depletion after unilateral ureteral obstruction in rats. Nephron. Exp. Nephrol. 105:e1-9.
14. Kitamoto K, et al. (2009) Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy. J. Pharmacol. Sci. 111:285-92.
15. Wang Y, et al. (2007) Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int. 72:290-9.
16. Vinuesa E, et al. (2008) Macrophage involvement in the kidney repair phase after ischaemia/ reperfusion injury. J. Pathol. 214:104-13.
17. Mosser DM, Edwards JP. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-69.
18. Loke P, et al. (2007) Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J. Immunol. 179:3926-36.
19. Brandt E, Woerly G, Younes AB, Loiseau S, Capron M. (2000) IL-4 production by human polymorphonuclear neutrophils. J. Leukoc. Biol. 68:125-30.
20. Wilson MS, Wynn TA. (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2:103-21.
21. Reddy GK, Enwemeka CS. (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin. Biochem. 29:225-9.
22. Deamer D, Bangham AD. (1976) Large volume liposomes by an ether vaporization method. Biochim. Biophys. Acta. 443:629-34.
23. Tsuboi N, et al. (2002) Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J. Immunol. 169:2026-33.
24. Edgtton KL, Gow RM, Kelly DJ, Carmeliet P, Kitching AR. (2004) Plasmin is not protective in experimental renal interstitial fibrosis. Kidney Int. 66:68-76.
25. Tan AM, et al. (2010) TLR4 signaling in stromal cells is critical for the initiation of allergic Th2 responses to inhaled antigen. J. Immunol. 184:3535-44.
26. Sung SA, Jo SK, Cho WY, Won NH, Kim HK. (2007) Reduction of renal fibrosis as a result of liposome encapsulated clodronate induced macrophage depletion after unilateral ureteral obstruction in rats. Nephron. Exp. Nephrol. 105:e1-9.
27. Kitamoto K et al. (2009) Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy. J. Pharmacol. Sci. 111:285-92.
28. Wynn TA. (2003) IL-13 effector functions. Annu. Rev. Immunol. 21:425-56.
29. Lee SB, Kalluri R. (2010) Mechanistic connection between inflammation and fibrosis. Kidney Int. Suppl:S22-26.
30. Ziegler SF, Artis D. (2010) Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol. 11:289-93.
31. Tapmeier TT, et al. (2010) Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int. 78:351-62.
32. Shappell SB, Gurpinar T, Lechago J, Suki WN, Truong LD. (1998) Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: lymphocyte infiltration is not required for progressive tubulointerstitial injury. J. Am. Soc. Nephrol. 9:1008-17.
33. Jo SK, Sung SA, Cho WY, Go KJ, Kim HK. (2006) Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol. Dial. Transplant. 21:1231-9.
34. Lee S, et al. (2011) Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 22:317-26.
35. Patschan D, Patschan S, Gobe GG, Chintala S, Goligorsky MS. (2007) Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. J. Am. Soc. Nephrol. 18:1516-24.
36. Pazar B, et al. (2011) Basic calcium phosphate crystals induce monocyte/macrophage IL-1beta secretion through the NLRP3 inflammasome in vitro. J. Immunol. 186:2495-502.
37. Anders JH, Ryu M. (2011) Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 9:915-25.